[go: up one dir, main page]

FR2826261B1 - Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche - Google Patents

Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche

Info

Publication number
FR2826261B1
FR2826261B1 FR0108399A FR0108399A FR2826261B1 FR 2826261 B1 FR2826261 B1 FR 2826261B1 FR 0108399 A FR0108399 A FR 0108399A FR 0108399 A FR0108399 A FR 0108399A FR 2826261 B1 FR2826261 B1 FR 2826261B1
Authority
FR
France
Prior art keywords
alopeche
treatment
topical composition
cytotoxic product
cytotoxic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0108399A
Other languages
English (en)
Other versions
FR2826261A1 (fr
Inventor
Daniel Jean
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LMD SAS
Original Assignee
LMD SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LMD SAS filed Critical LMD SAS
Priority to FR0108399A priority Critical patent/FR2826261B1/fr
Priority to PCT/FR2002/002220 priority patent/WO2003000208A1/fr
Publication of FR2826261A1 publication Critical patent/FR2826261A1/fr
Application granted granted Critical
Publication of FR2826261B1 publication Critical patent/FR2826261B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0108399A 2001-06-26 2001-06-26 Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche Expired - Fee Related FR2826261B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0108399A FR2826261B1 (fr) 2001-06-26 2001-06-26 Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche
PCT/FR2002/002220 WO2003000208A1 (fr) 2001-06-26 2002-06-26 Composition a usage topique comprenant un produit cytotoxique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0108399A FR2826261B1 (fr) 2001-06-26 2001-06-26 Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche

Publications (2)

Publication Number Publication Date
FR2826261A1 FR2826261A1 (fr) 2002-12-27
FR2826261B1 true FR2826261B1 (fr) 2005-03-25

Family

ID=8864767

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0108399A Expired - Fee Related FR2826261B1 (fr) 2001-06-26 2001-06-26 Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche

Country Status (2)

Country Link
FR (1) FR2826261B1 (fr)
WO (1) WO2003000208A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2879444B1 (fr) * 2004-12-22 2007-05-18 Oreal Utilisation d'un compose capable d'augmenter le taux de glutathion dans les melanocytes pour le traitement de la canitie
EP1890683B1 (fr) * 2005-04-29 2011-06-08 Johns Hopkins University Procedes de traitement de la carcinogenese de la peau induite par le uv
FR2902325B1 (fr) * 2006-06-20 2009-12-04 Oreal Utilisation de 3h-1,2-dithiole-3-thione, d'anethole dithiomlethione, de sulforaphe, de phenethyl isothiocyanate, de 6-methyle-sulphinyl)hexyl isothiocyanate et d'allyl isothiocyanate pour le traitement de la canitie
FR2902329B1 (fr) * 2006-12-19 2011-07-01 Oreal Utilisation de sulforaphane, de phenethyl isothiocyanate, de 6-methyl-sulphinyl)hexyl isothiocyanate et d'allyl isothiocyanate pour le traitement de la canitie.
CN101897691B (zh) * 2009-05-31 2013-06-05 无锡杰西医药科技有限公司 异硫氰酸酯类化合物在促进毛发生长中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE20640T1 (de) * 1983-03-01 1986-07-15 Rudolf Dr Trensch Haarbehandlungsmittel und haarbehandlungsverfahren.
US4571335A (en) * 1983-06-17 1986-02-18 Taylor Robert C Method of inhibiting herpetic lesions by the use of platinum coordination compounds
LU85849A1 (fr) * 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
EP0227799A4 (fr) * 1985-06-20 1987-10-05 Farmacon Inc Isothiocyanate allylique et utilisation dudit compose destine a empecher la chute des cheveux.
DE3901551A1 (de) * 1989-01-20 1990-07-26 Lohmann Therapie Syst Lts Superfizielles therapeutisches system mit einem gehalt an einem antineoplastischen wirkstoff, insbesondere 5-fluoruracil
US5214041A (en) * 1989-06-12 1993-05-25 Shiseido Company Ltd. Hair revitalizing tonic composition
JPH03153614A (ja) * 1989-11-09 1991-07-01 Minato Sangyo Kk 育毛剤
US6203782B1 (en) * 1990-03-02 2001-03-20 Universal Biologics, Inc. Method and product for promoting hair growth and treating skin conditions
WO1991014424A1 (fr) * 1990-03-28 1991-10-03 Yunis Adel A Procedes de protection contre la chute des cheveux provoquee par la chimiotherapie
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
CA2408152A1 (fr) * 2000-05-05 2001-11-15 Wisconsin Alumni Research Foundation Compositions et methodes permettant de proteger des cellules pendant le traitement du cancer par chimiotherapie et radiotherapie

Also Published As

Publication number Publication date
FR2826261A1 (fr) 2002-12-27
WO2003000208A1 (fr) 2003-01-03

Similar Documents

Publication Publication Date Title
MA26790A1 (fr) Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
FR15C0069I2 (fr) Formulation a usage topique d'ivermectine pour le traitement de conditions dermatologiques
EP1689348A4 (fr) Composition d'oligosaccharides et leur utilisation dans le traitement d'infection
FR15C0030I2 (fr) Composes d'acide benzoique 1,2,4-oxadiazole et utilisation de ceux-ci dans la suppression non-sens et le traitement de maladies
HUP0100127A3 (en) Detergent hair care composition containing amphoteric starch and its use
ZA200300788B (en) Improvements in and relating to the use of honey in dressings.
AP2003002726A0 (en) Azabicyclic compounds preparation thereof and use as medicines in particular as antibacterial agents
FI20020195L (fi) Metallikomplekseja, jotka sisältävät 2,6-diasyylipyridiiniligandin, ja niiden käyttö eteenin polymerointiin
MA26553A1 (fr) Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
FR2834459B1 (fr) Agent microbicide et composition de traitement cosmetique le contenant
FR2774687B1 (fr) Lipopeptides contenant un fragment de l'interferon gamma, et leur utilisation dans des compositions pharmaceutiques
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
FR2812197B1 (fr) Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
GB0019302D0 (en) Biological materials and the use thereof for the treatment of disease
PT1228039E (pt) N-guanidinoalquilamidas sua preparacao sua utilizacao e preparacoes farmaceuticas contendo as mesmas
HUP0201997A2 (en) Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
IL160018A0 (en) Isoxazolopyridinones and use thereof in the treatment of parkinson's disease
EP1429604A4 (fr) Compositions fongicides et applications correspondantes dans l'agriculture
FR2826261B1 (fr) Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
DZ3320A1 (fr) Complexe comprenant de l'eletriptane et de la sulphobutylether-cyclodextrine pour le traitement de la migraine
EP0840605A4 (fr) Composes utiles dans le traitement des neurofibromatoses
FR2733418B1 (fr) Nouvelles associations comprenant du (-) hydroxycitrate et presentant notamment de nouvelles activites therapeutiques
FR2710266B1 (fr) Nouvelles compositions en cosmétologie et dermatologie proposées dans le traitement des verrues.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20060228